tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market

Takara Bio Inc. (4974) Ratios

Compare
2 Followers

Takara Bio Inc. Ratios

JP:4974's free cash flow for Q3 2025 was ¥0.37. For the 2025 fiscal year, JP:4974's free cash flow was decreased by ¥ and operating cash flow was ¥-0.26. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
5.47 8.09 8.76 5.40 3.92
Quick Ratio
3.83 6.34 7.10 4.62 2.54
Cash Ratio
2.54 4.14 4.63 3.41 1.28
Solvency Ratio
-0.07 0.47 0.57 1.24 1.22
Operating Cash Flow Ratio
0.54 0.82 0.24 2.57 0.40
Short-Term Operating Cash Flow Coverage
0.00 0.00 9.51 244.35 50.99
Net Current Asset Value
¥ 13.61B¥ 45.91B¥ 51.34B¥ 60.82B¥ 48.49B
Leverage Ratios
Debt-to-Assets Ratio
0.08 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.10 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
0.09 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.09 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.29 1.10 1.10 1.15 1.21
Debt Service Coverage Ratio
-3.88 279.60 32.30 118.90 150.50
Interest Coverage Ratio
-2.63 113.15 130.57 855.88 1.26K
Debt to Market Cap
0.07 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
86.58 9.31 8.23 8.27 8.89
Net Debt to EBITDA
106.87 -4.38 -4.08 -1.85 -0.67
Profitability Margins
Gross Profit Margin
53.99%57.88%61.85%57.29%72.69%
EBIT Margin
-11.79%4.49%6.61%27.19%40.70%
EBITDA Margin
-0.21%14.44%18.16%33.25%46.83%
Operating Profit Margin
-2.53%5.02%6.90%26.29%42.69%
Pretax Profit Margin
-12.68%4.43%6.56%27.16%40.67%
Net Profit Margin
-16.30%2.31%3.40%20.49%29.32%
Continuous Operations Profit Margin
-16.20%2.41%3.47%20.54%29.41%
Net Income Per EBT
128.63%52.18%51.88%75.44%72.09%
EBT Per EBIT
500.09%88.25%95.00%103.33%95.26%
Return on Assets (ROA)
-5.52%0.82%1.20%12.39%17.15%
Return on Equity (ROE)
-6.73%0.90%1.33%14.27%20.70%
Return on Capital Employed (ROCE)
-0.91%1.88%2.59%17.89%29.39%
Return on Invested Capital (ROIC)
-0.91%1.02%1.37%13.49%21.19%
Return on Tangible Assets
-6.76%0.87%1.28%13.33%18.63%
Earnings Yield
-5.21%1.05%1.27%7.67%7.36%
Efficiency Ratios
Receivables Turnover
5.43 3.21 3.86 6.28 3.80
Payables Turnover
11.74 11.48 10.76 14.37 9.44
Inventory Turnover
1.58 1.53 1.40 3.01 0.77
Fixed Asset Turnover
0.71 0.79 0.89 1.91 1.86
Asset Turnover
0.34 0.35 0.35 0.60 0.59
Working Capital Turnover Ratio
1.24 0.85 0.73 1.37 1.56
Cash Conversion Cycle
267.30 321.12 321.35 153.98 532.42
Days of Sales Outstanding
67.17 113.59 94.68 58.14 95.99
Days of Inventory Outstanding
231.22 239.31 260.60 121.24 475.10
Days of Payables Outstanding
31.09 31.78 33.93 25.40 38.68
Operating Cycle
298.39 352.91 355.28 179.39 571.09
Cash Flow Ratios
Operating Cash Flow Per Share
35.10 48.53 14.21 306.42 58.01
Free Cash Flow Per Share
-69.63 -33.44 -91.91 257.57 -46.12
CapEx Per Share
104.72 81.97 106.12 48.85 104.13
Free Cash Flow to Operating Cash Flow
-1.98 -0.69 -6.47 0.84 -0.80
Dividend Paid and CapEx Coverage Ratio
0.29 0.49 0.10 3.75 0.48
Capital Expenditure Coverage Ratio
0.34 0.59 0.13 6.27 0.56
Operating Cash Flow Coverage Ratio
0.42 5.31 1.77 37.96 6.67
Operating Cash Flow to Sales Ratio
0.10 0.13 0.04 0.47 0.10
Free Cash Flow Yield
-6.07%-4.04%-9.51%14.86%-2.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-19.19 95.69 78.60 13.03 13.60
Price-to-Sales (P/S) Ratio
3.13 2.21 2.67 2.67 3.99
Price-to-Book (P/B) Ratio
1.37 0.86 1.04 1.86 2.81
Price-to-Free Cash Flow (P/FCF) Ratio
-16.47 -24.76 -10.51 6.73 -48.59
Price-to-Operating Cash Flow Ratio
32.68 17.06 67.98 5.66 38.63
Price-to-Earnings Growth (PEG) Ratio
1.50 -3.23 -0.87 -0.67 0.13
Price-to-Fair Value
1.37 0.86 1.04 1.86 2.81
Enterprise Value Multiple
-1.39K 10.96 10.65 6.18 7.85
Enterprise Value
128.28B 71.26B 84.12B 160.59B 248.74B
EV to EBITDA
-1.39K 10.96 10.65 6.18 7.85
EV to Sales
2.91 1.58 1.93 2.06 3.67
EV to Free Cash Flow
-15.30 -17.69 -7.60 5.18 -44.79
EV to Operating Cash Flow
30.36 12.19 49.16 4.35 35.61
Tangible Book Value Per Share
642.15 895.90 861.69 858.78 721.73
Shareholders’ Equity Per Share
839.16 959.19 926.01 931.94 796.19
Tax and Other Ratios
Effective Tax Rate
-0.28 0.46 0.47 0.24 0.28
Revenue Per Share
366.64 374.03 361.29 648.94 562.21
Net Income Per Share
-59.78 8.65 12.29 132.97 164.84
Tax Burden
1.29 0.52 0.52 0.75 0.72
Interest Burden
1.08 0.99 0.99 1.00 1.00
Research & Development to Revenue
0.16 0.15 0.19 0.11 0.09
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-0.59 5.61 1.16 1.74 0.25
Currency in JPY